156 related articles for article (PubMed ID: 24819235)
1. Updated trends in imaging use in men diagnosed with prostate cancer.
Porten SP; Smith A; Odisho AY; Litwin MS; Saigal CS; Carroll PR; Cooperberg MR;
Prostate Cancer Prostatic Dis; 2014 Sep; 17(3):246-51. PubMed ID: 24819235
[TBL] [Abstract][Full Text] [Related]
2. Contemporary trends in imaging test utilization for prostate cancer staging: data from the cancer of the prostate strategic urologic research endeavor.
Cooperberg MR; Lubeck DP; Grossfeld GD; Mehta SS; Carroll PR
J Urol; 2002 Aug; 168(2):491-5. PubMed ID: 12131295
[TBL] [Abstract][Full Text] [Related]
3. Time trends and characteristics of men choosing watchful waiting for initial treatment of localized prostate cancer: results from CaPSURE.
Harlan SR; Cooperberg MR; Elkin E; Lubeck DP; Meng M; Mehta SS; Carroll PR
J Urol; 2003 Nov; 170(5):1804-7. PubMed ID: 14532780
[TBL] [Abstract][Full Text] [Related]
4. Patient demographics, quality of life, and disease features of men with newly diagnosed prostate cancer: trends in the PSA era.
Glass AS; Cowan JE; Fuldeore MJ; Cooperberg MR; Carroll PR; Kenfield SA; Greene KL
Urology; 2013 Jul; 82(1):60-5. PubMed ID: 23706257
[TBL] [Abstract][Full Text] [Related]
5. Examining initial treatment and survival among men with metastatic prostate cancer: An analysis from the CaPSURE registry.
Borno HT; Cowan JE; Zhao S; Broering JM; Carroll PR; Ryan CJ
Urol Oncol; 2020 Oct; 38(10):793.e1-793.e11. PubMed ID: 32782182
[TBL] [Abstract][Full Text] [Related]
6. Use of imaging tests for staging newly diagnosed prostate cancer: trends from the CaPSURE database.
Kindrick AV; Grossfeld GD; Stier DM; Flanders SC; Henning JM; Carroll PR
J Urol; 1998 Dec; 160(6 Pt 1):2102-6. PubMed ID: 9817332
[TBL] [Abstract][Full Text] [Related]
7. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
Sadetsky N; Elkin EP; Latini DM; DuChane J; Carroll PR;
Prostate Cancer Prostatic Dis; 2008; 11(3):280-7. PubMed ID: 17893700
[TBL] [Abstract][Full Text] [Related]
8. Risk assessment among prostate cancer patients receiving primary androgen deprivation therapy.
Cooperberg MR; Hinotsu S; Namiki M; Ito K; Broering J; Carroll PR; Akaza H
J Clin Oncol; 2009 Sep; 27(26):4306-13. PubMed ID: 19667269
[TBL] [Abstract][Full Text] [Related]
9. Impact of ethnicity on primary treatment choice and mortality in men with prostate cancer: data from CaPSURE.
Moses KA; Paciorek AT; Penson DF; Carroll PR; Master VA
J Clin Oncol; 2010 Feb; 28(6):1069-74. PubMed ID: 20100957
[TBL] [Abstract][Full Text] [Related]
10. Insurance and quality of life in men with prostate cancer: data from the Cancer of the Prostate Strategic Urological Research Endeavor.
Sadetsky N; Lubeck DP; Pasta DJ; Latini DM; DuChane J; Carroll PR
BJU Int; 2008 Mar; 101(6):691-7. PubMed ID: 18291018
[TBL] [Abstract][Full Text] [Related]
11. Bone scan overuse in staging of prostate cancer: an analysis of a Veterans Affairs cohort.
Palvolgyi R; Daskivich TJ; Chamie K; Kwan L; Litwin MS
Urology; 2011 Jun; 77(6):1330-6. PubMed ID: 21492911
[TBL] [Abstract][Full Text] [Related]
12. What percentage of patients with newly diagnosed carcinoma of the prostate are candidates for surveillance? An analysis of the CaPSURE database.
Barocas DA; Cowan JE; Smith JA; Carroll PR;
J Urol; 2008 Oct; 180(4):1330-4; discussion 1334-5. PubMed ID: 18707731
[TBL] [Abstract][Full Text] [Related]
13. The contemporary management of prostate cancer in the United States: lessons from the cancer of the prostate strategic urologic research endeavor (CapSURE), a national disease registry.
Cooperberg MR; Broering JM; Litwin MS; Lubeck DP; Mehta SS; Henning JM; Carroll PR;
J Urol; 2004 Apr; 171(4):1393-401. PubMed ID: 15017184
[TBL] [Abstract][Full Text] [Related]
14. A clinician-centred programme for behaviour change in the optimal use of staging investigations for newly diagnosed prostate cancer.
Rutledge AB; McLeod N; Mehan N; Regan TW; Ainsworth P; Chong P; Doyle T; White M; Sanson-Fisher RW; Martin JM
BJU Int; 2018 May; 121 Suppl 3():22-27. PubMed ID: 29359883
[TBL] [Abstract][Full Text] [Related]
15. Prostate brachytherapy: a descriptive analysis from CaPSURE.
Lee WR; Sharkey J; Cowan JE; DuChane J; Carroll PR;
Brachytherapy; 2007; 6(2):123-8. PubMed ID: 17434105
[TBL] [Abstract][Full Text] [Related]
16. Contemporary Trends in Magnetic Resonance Imaging at the Time of Prostate Biopsy: Results from a Large Private Insurance Database.
Kim SP; Karnes RJ; Mwangi R; Van Houten H; Gross CP; Gershman B; Leapman MS; Shah ND
Eur Urol Focus; 2021 Jan; 7(1):86-94. PubMed ID: 31047904
[TBL] [Abstract][Full Text] [Related]
17. Use of Evidence-Based Prostate Cancer Imaging in a Nongovernmental Integrated Health Care System.
Salloum RG; O'Keeffe-Rosetti M; Ritzwoller DP; Hornbrook MC; Lafata JE; Nielsen ME
J Oncol Pract; 2017 May; 13(5):e441-e450. PubMed ID: 28221895
[TBL] [Abstract][Full Text] [Related]
18. Treatment of patients with high risk localized prostate cancer: results from cancer of the prostate strategic urological research endeavor (CaPSURE).
Meng MV; Elkin EP; Latini DM; Duchane J; Carroll PR
J Urol; 2005 May; 173(5):1557-61. PubMed ID: 15821485
[TBL] [Abstract][Full Text] [Related]
19. Impact of androgen deprivation on physical well-being in patients with prostate cancer: analysis from the CaPSURE (Cancer of the Prostate Strategic Urologic Research Endeavor) registry.
Sadetsky N; Greene K; Cooperberg MR; Hubbard A; Carroll PR; Satariano W
Cancer; 2011 Oct; 117(19):4406-13. PubMed ID: 21412760
[TBL] [Abstract][Full Text] [Related]
20. Patterns of treatment of patients with prostate cancer initially managed with surveillance: results from The CaPSURE database. Cancer of the Prostate Strategic Urological Research Endeavor.
Koppie TM; Grossfeld GD; Miller D; Yu J; Stier D; Broering JM; Lubeck D; Henning JM; Flanders SC; Carroll PR
J Urol; 2000 Jul; 164(1):81-8. PubMed ID: 10840429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
